Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Egbert F Smit

Showing results (61-70 of 367) with videos related to

Pageof 37
Sort By:
International Journal of Molecular Sciences|June 18, 2020
Silencing Core Spliceosome Sm Gene Expression Induces a Cytotoxic Splicing Switch in the Proteasome Subunit Beta 3 mRNA in Non-Small Cell Lung Cancer CellsMaxime Blijlevens, Malgorzata A Komor, Rocco Sciarrillo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2007
Iris metastasis in small-cell lung carcinomaAnke W J Roenhorst, Alphons C M van den Bergh, John W G van Putten, et al.
The Oncologist|April 2, 2008
Critical review of nonsurgical treatment options for stage I non-small cell lung cancerCornelis J A Haasbeek, Suresh Senan, Egbert F Smit, et al.
European Journal of Cancer (Oxford, England : 1990)|October 28, 2018
Influenza vaccination in patients with lung cancer receiving anti-programmed death receptor 1 immunotherapy does not induce immune-related adverse eventsDirk H Wijn, Geert H Groeneveld, Albert M Vollaard, et al.
Pharmacoeconomics|December 29, 2011
Cost effectiveness of treatment with new agents in advanced non-small-cell lung cancer: a systematic reviewMathilda L Bongers, Veerle M H Coupé, Elise P Jansma, et al.
Clinical Lung Cancer|September 23, 2014
Rationale and study design of the IRENE-trial (NVALT-16): a phase II trial to evaluate iressa rechallenge in advanced NSCLC patients with an activating EGFR mutation who responded to an EGFR-TKI used as first-line or previous treatmentJustine L Kuiper, Danielle A M Heideman, Tom Würdinger, et al.
Cancer|September 28, 2010
Time for reappraisal of extracranial treatment options? Synchronous brain metastases from nonsmall cell lung cancerJoline S W Lind, Frank J Lagerwaard, Egbert F Smit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Measurement of perfusion in stage IIIA-N2 non-small cell lung cancer using H(2)(15)O and positron emission tomographyCorneline J Hoekstra, Sigrid G Stroobants, Otto S Hoekstra, et al.
Future Oncology (London, England)|September 1, 2025
Interstitial lung disease epidemiology and etiology in patients with solid malignant tumors: a systematic literature reviewEgbert F Smit, Simon M Collin, Manoj Prahladan, et al.
The Annals of Thoracic Surgery|May 30, 2017
Surgical Treatment of Complications After High-Dose Chemoradiotherapy for Lung CancerChris Dickhoff, Max Dahele, Sayed M Hashemi, et al.
Pageof 37

Showing results (61-70 of 367) with videos related to

Sort By:
Pageof 37
International Journal of Molecular Sciences|June 18, 2020
Silencing Core Spliceosome Sm Gene Expression Induces a Cytotoxic Splicing Switch in the Proteasome Subunit Beta 3 mRNA in Non-Small Cell Lung Cancer CellsMaxime Blijlevens, Malgorzata A Komor, Rocco Sciarrillo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2007
Iris metastasis in small-cell lung carcinomaAnke W J Roenhorst, Alphons C M van den Bergh, John W G van Putten, et al.
The Oncologist|April 2, 2008
Critical review of nonsurgical treatment options for stage I non-small cell lung cancerCornelis J A Haasbeek, Suresh Senan, Egbert F Smit, et al.
European Journal of Cancer (Oxford, England : 1990)|October 28, 2018
Influenza vaccination in patients with lung cancer receiving anti-programmed death receptor 1 immunotherapy does not induce immune-related adverse eventsDirk H Wijn, Geert H Groeneveld, Albert M Vollaard, et al.
Pharmacoeconomics|December 29, 2011
Cost effectiveness of treatment with new agents in advanced non-small-cell lung cancer: a systematic reviewMathilda L Bongers, Veerle M H Coupé, Elise P Jansma, et al.
Clinical Lung Cancer|September 23, 2014
Rationale and study design of the IRENE-trial (NVALT-16): a phase II trial to evaluate iressa rechallenge in advanced NSCLC patients with an activating EGFR mutation who responded to an EGFR-TKI used as first-line or previous treatmentJustine L Kuiper, Danielle A M Heideman, Tom Würdinger, et al.
Cancer|September 28, 2010
Time for reappraisal of extracranial treatment options? Synchronous brain metastases from nonsmall cell lung cancerJoline S W Lind, Frank J Lagerwaard, Egbert F Smit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Measurement of perfusion in stage IIIA-N2 non-small cell lung cancer using H(2)(15)O and positron emission tomographyCorneline J Hoekstra, Sigrid G Stroobants, Otto S Hoekstra, et al.
Future Oncology (London, England)|September 1, 2025
Interstitial lung disease epidemiology and etiology in patients with solid malignant tumors: a systematic literature reviewEgbert F Smit, Simon M Collin, Manoj Prahladan, et al.
The Annals of Thoracic Surgery|May 30, 2017
Surgical Treatment of Complications After High-Dose Chemoradiotherapy for Lung CancerChris Dickhoff, Max Dahele, Sayed M Hashemi, et al.
Pageof 37